FDA Digital Health Advisory Committee: November Meeting & What It Means

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

The Food and Drug Administration will convene a meeting of external digital health advisors on Nov. 6, according to an email reviewed by STAT. The gathering comes as the agency wrestles with myriad issues related to regulating artificial intelligence and other technologies in health care.

The email, addressed to members of and consultants to the FDA’s Digital Health Advisory Committee, said the virtual-only meeting would be announced publicly no later than Sept. 10. No topic was given, but the email said an agenda and discussion questions were forthcoming.

Another source involved with the committee told STAT they had not been notified of the meeting. The FDA did not immediately respond to a request for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

View All Plans